Clinical Trial Update: Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for hypofractionated accelerated radiotherapy with concomitant chemotherapy in non-small cell lung cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN